Cash flow AMN Healthcare Services, Inc.

Stocks

AMN

US0017441017

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 20:42:14 20/07/2026 BST			5-day change	1st Jan Change
33.78 ^USD	-3.47%		+0.38%	+116.43%

06-15	AMN Healthcare Services, Inc. Announces Executive Appointments, Effective June 15, 2026	CI
06-08	AMN Healthcare Services, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 09:20 AM

19d8.Qz_RoCC9VDPI91fwEQOwQbpQPB17nECKygiYaULNJxA.DlKVmUyJAmqSrWKbYE3ad_I8DVwSyhi8nzD2Kxa5U3siCKbuZ-QnZYu9bw

Published financial data: AMN HEALTHCARE SERVICES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.98B	5.24B	3.79B	2.98B	2.73B
Total Revenues	3.98B	5.24B	3.79B	2.98B	2.73B
Cost of Goods Sold, Total	2.67B	3.53B	2.54B	2.06B	1.96B
Gross Profit	1.31B	1.72B	1.25B	919M	774M
Selling General & Admin Expenses, Total	730M	940M	754M	632M	593M
Depreciation & Amortization - (IS)	101M	133M	155M	167M	148M
Other Operating Expenses, Total	832M	1.07B	909M	800M	741M
Operating Income	478M	644M	341M	120M	33.17M
Interest Expense, Total	-40.78M	-	-54.14M	-69.9M	-45.59M
Net Interest Expenses	-40.78M	-	-54.14M	-69.9M	-45.59M
Other Non Operating Income (Expenses)	-	-37M	-	-	-
EBT, Excl. Unusual Items	437M	607M	287M	49.88M	-12.42M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-222M	-110M
Gain (Loss) On Sale Of Investments	6.7M	-3.4M	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	39.14M
Asset Writedown	-	-	-	-	-18.26M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	2.93M	-2.43M	-	-
EBT, Incl. Unusual Items	444M	607M	284M	-173M	-101M
Income Tax Expense	117M	163M	73.61M	-25.6M	-5.36M
Earnings From Continuing Operations	327M	444M	211M	-147M	-95.7M
Net Income to Company	327M	444M	211M	-147M	-95.7M
Net Income - (IS)	327M	444M	211M	-147M	-95.7M
Net Income to Common Incl Extra Items	327M	444M	211M	-147M	-95.7M
Net Income to Common Excl. Extra Items	327M	444M	211M	-147M	-95.7M
Per Share Items
Net EPS - Basic	6.87	9.96	5.38	-3.85	-2.48
Basic EPS - Continuing Operations	6.87	9.96	5.38	-3.85	-2.48
Basic Weighted Average Shares Outstanding	47.68M	44.59M	39.17M	38.19M	38.52M
Net EPS - Diluted	6.81	9.9	5.36	-3.85	-2.48
Diluted EPS - Continuing Operations	6.81	9.9	5.36	-3.85	-2.48
Diluted Weighted Average Shares Outstanding	48.04M	44.87M	39.34M	38.19M	38.52M
Normalized Basic EPS	5.73	8.51	4.57	0.82	-0.2
Normalized Diluted EPS	5.69	8.46	4.56	0.82	-0.2
Supplemental Items
EBITDA	582M	781M	502M	294M	190M
EBITA	541M	727M	431M	213M	111M
EBIT	478M	644M	341M	120M	33.17M
EBITDAR	614M	807M	518M	308M	203M
Effective Tax Rate - (Ratio)	26.25	26.81	25.89	14.83	5.3
Current Domestic Taxes	133M	187M	86.54M	25.47M	14.24M
Current Foreign Taxes	-	-	-	-	-47K
Total Current Taxes	133M	187M	86.54M	25.47M	14.19M
Deferred Domestic Taxes	-16.29M	-24.62M	-12.93M	-51.07M	-19.6M
Deferred Foreign Taxes	-	-	-	-	47K
Total Deferred Taxes	-16.29M	-24.62M	-12.93M	-51.07M	-19.55M
Normalized Net Income	273M	379M	179M	31.18M	-7.76M
Interest Capitalized	349K	703K	1.23M	606K	229K
Supplemental Operating Expense Items
Net Rental Expense, Total	32.04M	25.36M	16.14M	14.11M	12.82M
Imputed Operating Lease Interest Expense	11.57M	165K	6.46M	6.5M	4.94M
Imputed Operating Lease Depreciation	20.47M	25.19M	9.67M	7.61M	7.87M
Stock-Based Comp., SG&A Exp. (Total)	25.22M	30.07M	18.02M	23.32M	30.68M
Total Stock-Based Compensation	25.22M	30.07M	18.02M	23.32M	30.68M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	181M	64.52M	32.94M	10.65M	33.97M
Total Cash And Short Term Investments	181M	64.52M	32.94M	10.65M	33.97M
Accounts Receivable, Total	1.03B	944M	741M	508M	431M
Other Receivables	-	8.88M	5.35M	11.68M	8.51M
Total Receivables	1.03B	953M	747M	520M	439M
Prepaid Expenses	72.46M	18.71M	21.89M	22.51M	20.87M
Restricted Cash	29.26M	37.22M	22.06M	14.98M	21.63M
Other Current Assets, Total	37.57M	19.94M	18.26M	26.79M	29.8M
Total Current Assets	1.35B	1.09B	842M	595M	545M
Gross Property Plant And Equipment	345M	393M	511M	579M	578M
Accumulated Depreciation	-190M	-228M	-285M	-361M	-415M
Net Property Plant And Equipment	155M	166M	226M	218M	163M
Long-term Investments	-	-	-	-	-
Goodwill	892M	935M	1.11B	897M	756M
Other Intangibles, Total	514M	477M	474M	381M	284M
Deferred Tax Assets Long-Term	-	-	-	25.83M	44.88M
Other Long-Term Assets, Total	221M	217M	271M	298M	301M
Total Assets	3.13B	2.89B	2.92B	2.42B	2.09B
Liabilities
Accounts Payable, Total	339M	373M	177M	101M	84.94M
Accrued Expenses, Total	423M	415M	369M	353M	362M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	11.38M	8.09M	7.99M	6.2M	6.01M
Current Income Taxes Payable	21.16M	-	-	-	-
Unearned Revenue Current, Total	15.95M	11.82M	11.3M	10.01M	9.5M
Other Current Liabilities	159M	49.82M	91.16M	75.45M	115M
Total Current Liabilities	969M	858M	656M	546M	578M
Long-Term Debt	842M	844M	1.3B	1.06B	767M
Long-Term Leases	13.36M	9.36M	37.6M	35.72M	30.14M
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	47.81M	22.71M	23.35M	-	-
Other Non Current Liabilities	96.99M	111M	71.38M	71.72M	77.19M
Total Liabilities	1.97B	1.84B	2.09B	1.71B	1.45B
Common Stock, Total	498K	501K	504K	507K	511K
Additional Paid In Capital	487M	502M	507M	528M	559M
Retained Earnings	797M	1.24B	1.45B	1.3B	1.21B
Treasury Stock	-122M	-699M	-1.13B	-1.13B	-1.13B
Comprehensive Income and Other	-295K	-939K	-423K	-11K	298K
Total Common Equity	1.16B	1.04B	831M	707M	642M
Total Equity	1.16B	1.04B	831M	707M	642M
Total Liabilities And Equity	3.13B	2.89B	2.92B	2.42B	2.09B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	46.64M	41.07M	37.89M	38.19M	38.64M
ECS Total Common Shares Outstanding	47.26M	41.88M	37.81M	38.08M	38.44M
Book Value / Share	24.59	24.92	21.99	18.56	16.7
Tangible Book Value	-245M	-369M	-754M	-572M	-397M
Tangible Book Value Per Share	-5.18	-8.8	-19.95	-15.03	-10.33
Total Debt	867M	861M	1.35B	1.1B	803M
Net Debt	686M	796M	1.32B	1.09B	769M
Debt Equivalent Oper. Leases	256M	203M	129M	113M	103M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	43.13M	51.41M	71.82M	90.97M	97.88M
Full Time Employees	3.8K	4.23K	3.58K	2.97K	2.66K
Accumulated Allowance for Doubtful Accounts (Supple)	6.84M	31.91M	32.23M	32.42M	16.58M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	327M	444M	211M	-147M	-95.7M
Depreciation & Amortization - CF	40.68M	54.03M	71.17M	81.01M	78.57M
Amortization of Goodwill and Intangible Assets - (CF)	63.02M	83.08M	89.76M	92.77M	78.03M
Depreciation & Amortization, Total	104M	137M	161M	174M	157M
Amortization of Deferred Charges, Total - (CF)	158K	-	-	-	1.16M
(Gain) Loss From Sale Of Asset	2.71M	1.56M	8.05M	65K	-20.84M
(Gain) Loss on Sale of Investments - (CF)	-52K	749K	302K	200K	-106K
Asset Writedown & Restructuring Costs	-	-	-	222M	110M
Stock-Based Compensation (CF)	25.24M	29.54M	18.48M	22.09M	32.97M
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	6.26M	58M	23.91M	3.3M	2.48M
Other Operating Activities, Total	-16.55M	-16.72M	-63K	-40.4M	-17.65M
Change In Accounts Receivable	-585M	28.91M	221M	223M	71.57M
Change In Accounts Payable	256M	48.78M	-184M	-155M	-20.57M
Change in Unearned Revenues	4.32M	-4.1M	-558K	-1.34M	6.02M
Change In Income Taxes	6.59M	-8.88M	3.79M	-4.01M	3.18M
Change in Other Net Operating Assets	175M	-65.28M	-90.9M	22.7M	40.84M
Cash from Operations	305M	654M	372M	320M	269M
Capital Expenditure	-53.57M	-75.83M	-104M	-80.89M	-35.63M
Cash Acquisitions	-41.26M	-69.57M	-292M	-	-
Divestitures	-	-	-	-	65.28M
Sale (Purchase) of Intangible assets	-90K	-5.09M	-1.7M	-	-
Investment in Marketable and Equity Securities, Total	-422K	-	9.97M	7.72M	-25.37M
Other Investing Activities, Total	-12.05M	-20.22M	-24.9M	-6.76M	22K
Cash from Investing	-107M	-171M	-412M	-79.94M	4.3M
Long-Term Debt Issued, Total	70M	-	815M	125M	530M
Total Debt Issued	70M	-	815M	125M	530M
Long-Term Debt Repaid, Total	-91.88M	-	-355M	-375M	-815M
Total Debt Repaid	-91.88M	-	-355M	-375M	-815M
Repurchase of Common Stock	-9.92M	-592M	-438M	-8.48M	-2.09M
Other Financing Activities, Total	-3.1M	-	-11.08M	-973K	-8.8M
Cash from Financing	-34.9M	-592M	10.73M	-259M	-296M
Foreign Exchange Rate Adjustments	-335K	-	-	-	-
Net Change in Cash	163M	-109M	-29.6M	-18.97M	-22.13M
Supplemental Items
Cash Interest Paid	38.08M	37.52M	48.1M	61.03M	45.11M
Cash Income Tax Paid (Refund)	106M	214M	78.26M	28.15M	7.85M
Levered Free Cash Flow	240M	520M	271M	263M	250M
Unlevered Free Cash Flow	265M	520M	305M	307M	277M
Change In Net Working Capital	109M	-30.86M	-18.66M	-116M	-105M
Net Debt Issued / Repaid	-21.88M	-	460M	-250M	-285M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.89	13.38	7.33	2.8	0.92
Return on Total Capital	15.71	20.47	10.43	3.76	1.28
Return On Equity %	33.04	40.26	22.47	-19.11	-14.19
Return on Common Equity	33.04	40.26	22.47	-19.11	-14.19
Margin Analysis
Gross Profit Margin %	32.87	32.74	32.98	30.81	28.35
SG&A Margin	18.33	17.92	19.89	21.2	21.72
EBITDA Margin %	14.6	14.9	13.24	9.84	6.95
EBITA Margin %	13.58	13.87	11.36	7.12	4.07
EBIT Margin %	12	12.29	9	4.01	1.21
Income From Continuing Operations Margin %	8.22	8.47	5.56	-4.93	-3.5
Net Income Margin %	8.22	8.47	5.56	-4.93	-3.5
Net Avail. For Common Margin %	8.22	8.47	5.56	-4.93	-3.5
Normalized Net Income Margin	6.86	7.24	4.73	1.04	-0.28
Levered Free Cash Flow Margin	6.02	9.91	7.16	8.83	9.15
Unlevered Free Cash Flow Margin	6.66	9.91	8.06	10.29	10.15
Asset Turnover
Asset Turnover	1.45	1.74	1.3	1.12	1.21
Fixed Assets Turnover	22.85	32.73	19.36	13.43	14.3
Receivables Turnover (Average Receivables)	5.39	5.31	4.5	4.78	5.82
Short Term Liquidity
Current Ratio	1.39	1.27	1.28	1.09	0.94
Quick Ratio	1.25	1.19	1.19	0.97	0.82
Operating Cash Flow to Current Liabilities	0.31	0.76	0.57	0.59	0.47
Days Sales Outstanding (Average Receivables)	67.74	68.68	81.18	76.63	62.76
Average Days Payable Outstanding	30.46	36.86	39.55	24.65	17.34
Long Term Solvency
Total Debt/Equity	74.62	82.5	162.44	155.36	125.09
Total Debt / Total Capital	42.73	45.2	61.9	60.84	55.57
LT Debt/Equity	73.64	81.72	161.48	154.48	124.15
Long-Term Debt / Total Capital	42.17	44.78	61.53	60.5	55.16
Total Liabilities / Total Assets	62.9	63.87	71.58	70.75	69.34
EBIT / Interest Expense	11.72	-	6.3	1.71	0.73
EBITDA / Interest Expense	15.05	-	9.57	4.4	4.44
(EBITDA - Capex) / Interest Expense	13.74	-	7.65	3.24	3.66
Total Debt / EBITDA	1.41	1.07	2.61	3.57	3.96
Net Debt / EBITDA	1.12	0.99	2.54	3.53	3.8
Total Debt / (EBITDA - Capex)	1.55	1.18	3.26	4.84	4.81
Net Debt / (EBITDA - Capex)	1.22	1.09	3.18	4.79	4.61
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	66.45	31.6	-27.73	-21.26	-8.49
Gross Profit, 1 Yr. Growth %	65.4	31.08	-27.21	-26.43	-15.81
EBITDA, 1 Yr. Growth %	123.88	34.31	-35.77	-41.5	-35.36
EBITA, 1 Yr. Growth %	135.79	34.42	-40.79	-50.64	-47.69
EBIT, 1 Yr. Growth %	188.59	34.76	-47.09	-64.86	-72.31
Earnings From Cont. Operations, 1 Yr. Growth %	363.3	35.63	-52.56	-169.76	-34.89
Net Income, 1 Yr. Growth %	363.3	35.63	-52.56	-169.76	-34.89
Normalized Net Income, 1 Yr. Growth %	276.3	38.87	-52.51	-82.6	-124.91
Diluted EPS Before Extra, 1 Yr. Growth %	360.14	45.37	-45.86	-171.83	-35.47
Accounts Receivable, 1 Yr. Growth %	128.59	-8.21	-21.52	-31.42	-15.29
Net Property, Plant and Equip., 1 Yr. Growth %	-20.12	6.88	36.48	-3.34	-25.17
Total Assets, 1 Yr. Growth %	33.07	-7.78	1.25	-17.39	-13.31
Tangible Book Value, 1 Yr. Growth %	-59.85	50.57	104.69	-24.15	-30.58
Common Equity, 1 Yr. Growth %	41.77	-10.19	-20.35	-14.99	-9.13
Cash From Operations, 1 Yr. Growth %	18.9	114.09	-43.07	-13.9	-15.9
Capital Expenditures, 1 Yr. Growth %	42.1	41.55	36.73	-21.99	-55.95
Levered Free Cash Flow, 1 Yr. Growth %	45.18	95.89	-45.11	-2.98	-5.09
Unlevered Free Cash Flow, 1 Yr. Growth %	38.72	96.01	-41.27	0.58	-9.69
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	33.9	48	-2.48	-24.56	-15.11
Gross Profit, 2 Yr. CAGR %	32.72	47.25	-2.32	-26.82	-21.29
EBITDA, 2 Yr. CAGR %	54.84	73.41	-7.12	-38.7	-38.98
EBITA, 2 Yr. CAGR %	71.43	109.54	-5.09	-42.56	-43.53
EBIT, 2 Yr. CAGR %	61.14	97.21	-15.55	-56.88	-69.16
Earnings From Cont. Operations, 2 Yr. CAGR %	69.47	150.68	-19.78	-42.47	-32.6
Net Income, 2 Yr. CAGR %	69.47	150.68	-19.78	-42.47	-32.6
Normalized Net Income, 2 Yr. CAGR %	67.59	137.23	-19.63	-71.26	-79.46
Diluted EPS Before Extra, 2 Yr. CAGR %	68.45	158.63	-11.28	-37.64	-31.92
Accounts Receivable, 2 Yr. CAGR %	55.52	44.85	-15.12	-26.64	-23.78
Net Property, Plant and Equip., 2 Yr. CAGR %	-10.81	-7.6	20.78	14.86	-14.95
Total Assets, 2 Yr. CAGR %	27.33	10.78	-3.37	-8.55	-15.38
Tangible Book Value, 2 Yr. CAGR %	-2.46	-22.25	75.56	24.6	-27.44
Common Equity, 2 Yr. CAGR %	25.59	12.84	-15.42	-17.72	-12.11
Cash From Operations, 2 Yr. CAGR %	16.53	59.54	10.4	-29.99	-14.91
Capital Expenditures, 2 Yr. CAGR %	23.34	41.82	39.12	3.28	-41.38
Levered Free Cash Flow, 2 Yr. CAGR %	14.2	63.58	5.47	-27.02	-4.89
Unlevered Free Cash Flow, 2 Yr. CAGR %	14.84	64.9	7.3	-23.14	-5.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	23.1	33.13	16.54	-9.19	-19.55
Gross Profit, 3 Yr. CAGR %	23.43	32.17	16.43	-11.12	-23.32
EBITDA, 3 Yr. CAGR %	34.02	47.67	24.53	-20.38	-37.61
EBITA, 3 Yr. CAGR %	39.24	58.08	37.5	-23.67	-44.32
EBIT, 3 Yr. CAGR %	33.6	51.82	27.2	-36.95	-62.8
Earnings From Cont. Operations, 3 Yr. CAGR %	32.19	57.35	43.93	-23.43	-40.04
Net Income, 3 Yr. CAGR %	32.19	57.35	43.93	-23.43	-40.04
Normalized Net Income, 3 Yr. CAGR %	33.37	57.41	38.51	-51.74	-72.6
Diluted EPS Before Extra, 3 Yr. CAGR %	32.77	60.38	53.57	-17.31	-36.92
Accounts Receivable, 3 Yr. CAGR %	35.23	30.45	18.09	-20.95	-23.03
Net Property, Plant and Equip., 3 Yr. CAGR %	19.65	-5.26	5.23	12.13	-0.43
Total Assets, 3 Yr. CAGR %	28.02	14.35	7.51	-8.29	-10.16
Tangible Book Value, 3 Yr. CAGR %	24.89	12.73	7.36	32.72	2.53
Common Equity, 3 Yr. CAGR %	22.06	12.31	0.47	-15.28	-14.95
Cash From Operations, 3 Yr. CAGR %	10.39	42.72	13.16	1.62	-25.58
Capital Expenditures, 3 Yr. CAGR %	15.02	29.13	40.1	14.72	-22.26
Levered Free Cash Flow, 3 Yr. CAGR %	13.48	41.39	11.8	2.57	-20.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.16	37.24	16.89	5.01	-18.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.94	21.4	12.15	6.07	2.67
Gross Profit, 5 Yr. CAGR %	16.14	21.65	12.4	4.34	-0.45
EBITDA, 5 Yr. CAGR %	21.33	26.11	15.73	3.89	-6.09
EBITA, 5 Yr. CAGR %	20.85	27.88	16.53	2.92	-7.66
EBIT, 5 Yr. CAGR %	20.06	24.82	11.2	-8.24	-27.5
Earnings From Cont. Operations, 5 Yr. CAGR %	25.34	27.35	8.25	5.22	6.25
Net Income, 5 Yr. CAGR %	25.34	27.35	8.25	5.22	6.25
Normalized Net Income, 5 Yr. CAGR %	19.94	25.77	9.24	-20.36	-35.1
Diluted EPS Before Extra, 5 Yr. CAGR %	25.93	29.87	12.99	9.91	10.92
Accounts Receivable, 5 Yr. CAGR %	21.34	19.26	12.24	3.62	-0.88
Net Property, Plant and Equip., 5 Yr. CAGR %	20.9	17.65	20.1	2.32	-3.36
Total Assets, 5 Yr. CAGR %	21.42	18.16	14.4	4.57	-2.31
Tangible Book Value, 5 Yr. CAGR %	12.13	134.79	43.11	17.33	-8.21
Common Equity, 5 Yr. CAGR %	20.93	13.16	5.4	-0.83	-4.77
Cash From Operations, 5 Yr. CAGR %	17.92	32.43	10.39	7.34	0.96
Capital Expenditures, 5 Yr. CAGR %	19.53	23.37	24.11	18.09	-1.12
Levered Free Cash Flow, 5 Yr. CAGR %	16.3	35.97	10.59	7.45	5.17
Unlevered Free Cash Flow, 5 Yr. CAGR %	16.72	33.17	11.95	8.84	7.72